The bioprocess technologies industry is anticipated to develop at 15.two% CAGR from 2022 to 2029. It is anticipated to attain above USD 61805.63 million by 2029 from USD17296.four million in 2022.

Luton, Bedfordshire, United Kingdom, March 18, 2023 (GLOBE NEWSWIRE) —

Exactitude Consultancy, the industry study and consulting wing of Ameliorate Digital Consultancy Private Restricted has completed and published the final copy of the detailed study report on the Bioprocess Technologies Industry.

Bioprocess technologies is anticipated to be in good demand from the pharmaceutical sector due to the increasing incidence of infectious and chronic illnesses such as cancer. The general development of the industry is anticipated to be driven by advances in the biotechnology and biopharmaceutical sector, escalating R&ampD expenditures, expanding vaccine production, and technological advancements. Biopharmaceutical outsourcing has emerged as a lucrative technique to address the unmet healthcare desires of sufferers. This has led to a expanding quantity of bioprocess systems with enhanced procedure efficiency and throughput. These systems provide positive aspects in adhering to regulatory compliance processes. Several biopharmaceutical organizations are opting for single-use systems. This is to deliver expense efficiencies and technological advances via enhanced processing energy and capacity. On the other hand, Strict supervision policies and higher expense of technologies re obstructing the Bioprocess Technologies Industry.

A single of the driving forces for Bioprocess Technologies industry is escalating funding for Bioprocess Technologies

Click &amp Get No cost Sample Report in Minutes:

Development Drivers

The sales figures of bioprocess technologies are becoming driven by an escalating emphasis on preventative measures as properly as option medicines for distinct purposes. Crucial components affecting general industry improvement incorporate the opening of new production facilities and the expansion of established ones in emerging markets.

Story continues

The improvement of new technologies to address efficiency and good quality troubles connected to the production of bioprocess items has resulted in enhanced investments more than the previous 5 years, which has led to a substantial advancement in the field of bioprocess technologies.

The preference for bio-primarily based goods created from fossil and biodegradable fuels is altering, opening up new improvement possibilities.

Crucial Components affecting industry development incorporate opening of new manufacturing facility.

Crucial components impacting general industry development incorporate the opening of new manufacturing facilities and the expansion of current facilities in emerging regions. The improvement of new technologies to address the efficiency and good quality challenges linked with the manufacture of bioprocess items has led to enhanced investment more than the previous 5 years, considerably advancing the field of bioprocess technologies.

The pharmaceutical sector is anticipated to see substantial demand for bioprocessing technologies due to the enhance in chronic illnesses such as infectious illnesses and cancer. Biopharmaceutical outsourcing is emerging as a productive way to address the unmet healthcare desires of sufferers. This has led to the development of bioprocessing systems with larger throughput and larger procedure efficiency.

Competitive Insight

Some of the notable industry players operating in the international Bioprocess Technologies Industry covered in this report is:

  • Sophisticated Instruments

  • Agilent Technologies, Inc.

  • Becton

  • Dickinson And Organization

  • Bio-Rad Laboratories, Inc

  • Hoffmann-La Roche Ltd

  • Gonotec Gmbh

  • Knauer Wissenschaftliche Gerate Gmbh

  • Merck KGAA

  • Sartorius Group

  • Thermo Fisher Scientific, Inc *The Organization List Is Indicative

Current Developments

In October 2022, Thermo Fisher Scientific Inc. launched a substantial-scale cell culture harvesting resolution. This, DynaSpin single-use centrifuge program, a centrifuge that is particularly created to deliver an optimal single-use resolution for substantial-scale cell culture harvesting, to enhance and streamline the procedure by decreasing the quantity of depth filtration cartridges needed to comprehensive the harvest procedure.

June 15, 2022 – Sophisticated Instruments, a major manufacturer of scientific and analytical instruments and solutions for the clinical, biopharmaceutical and meals and beverage sectors lately announced that it has expanded its direct sales presence in France for the biopharmaceutical and meals and beverage markets via its French subsidiary, Sophisticated Instruments SAS.

With this expansion, the organization has deployed a regional sales and marketing and advertising group specialized in bioprocessing, a field application scientist group, a technical service group, consumer assistance sources, and central European warehousing. Sophisticated Instruments has sold a portfolio of osmometers and cryoscopes for much more than 30 years in France via distribution partners, and with a direct presence it will improve its consumer engagement and assistance demonstrating its commitment to this vital industry.

Browse the complete “Bioprocess Technologies Industry Report, By Item Form (Biologics Security Testing, Cell Counting, Cell Culture, Cell Expansion, Cell Line Improvement, Flow Cytometry, Tangential Flow Filtration), Application (Antibiotics, Biosimilars, Recombinant Proteins, Other folks), Finish User (Biopharmaceutical Providers, Contract Manufacturing Organization, Academic Investigation Institutes, Meals and Feed Market, Contract Investigation Organization) and Geography – International Industry Share, Trend Evaluation &amp Forecast , 2022- 2029” Report and TOC at

Segment Overview

The Bioprocess Technologies industry is segmented By Item Form, By Application, and By Finish User.

By Form

 By Application

By Finish User

  • Antibiotics

  • Biosimilars

  • Recombinant proteins

  • Other folks

  • Biopharmaceutical organizations

  • Contract manufacturing organization

  • Academic study institutes

  • Meals and feed sector

  • Contract study organization


To find out much more about this report, request a free of charge sample copy

Regional Insights

North America, the biggest industry in 2021 accounted for much more income generation of worldwide sales and is most likely to dominate the industry more than the estimated period. The development of the area is attributed to the escalating demand for higher-good quality biologics, the substantial presence of many domestic and international industry players, and the escalating investment in study and improvement activities of these industry players.

Quantitative Evaluation

  • Industry size, estimates, and forecasts from 2023 – 2029

  • Industry size and income estimates for item up to 2029

  • Industry income estimates for application up to 2029

  • Industry income estimates for kind up to 2029

  • Regional industry size and forecast up to 2029

  • Organization economic

What are the Crucial Information Covered in this Bioprocess Technologies Industry Report?

  • CAGR of the industry throughout the forecast period 2023-2029

  • Detailed details on components that will drive Bioprocess Technologies Industry development throughout the subsequent Six years

  • Precise estimation of the Bioprocess Technologies Industry size and its contribution to the parent industry

  • Correct predictions on upcoming trends and adjustments in customer behaviour.

  • The development of the Bioprocess Technologies sector across North America, Europe, APAC, South America, the Middle East, and Africa

  • A thorough evaluation of the market’s competitive landscape and detailed details on vendors

  • Extensive specifics of components that will challenge the development of Bioprocess Technologies Industry vendors

To know an further revised 2023 list of industry players, request a sample report:

Browse Other Connected Investigation Reports from Exactitude Consultancy

Biomedical Textiles Industry to Register Impressive Development with Amazing CAGR Worth in Future. Since broken tissues or organs can be treated with biomedical textiles, demand for biomedical textiles has enhanced throughout the pandemic. This is the item of cutting-edge healthcare innovations in biomedical textiles.

Biomedical Textiles Market by Fiber Type (Biodegradable, Non-biodegradable), Fabric Type (Woven, Non-woven, Knitted), Application (Non-implantable, Surgical Sutures) and by Region, Global trends and forecast from 2022 to 2029

Bioinformatics Solutions Industry To Register Highly-priced Market Development throughout 2022-2029 | Major Top Players – Illumina, Thermo Fisher Scientific. Due to the positive aspects of employing informatic options for laboratory protocol generation, information administration, and evaluation, these options are anticipated to be in higher demand in the subsequent years.

Bioinformatics Services Market by Type (Sequencing, Data Analysis, Discovery, Gene Expression, Database Management), Specialty (Medical, Plant, Forensics), Application (Genomics, Metabolomics), End User (Academia, Pharma-Biotech) and by Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Global trends and forecast from 2022 to 2029

Bioinformatics Industry Anticipated to Witness Huge Development with a Tremendous CAGR of 15.four%. Developing bioinformatics applications in drug study and improvement, as properly as enhanced bioinformatics assistance in the creation of tailored medicines and clinical diagnostics, are driving up demand for bioinformatics industry.

Bioinformatics Market by Technology & Services (Knowledge Management Tools, Bioinformatics Platforms, and Bioinformatics Services), Application (Metabolomics, Molecular Phylogenetics, Transcriptomics, Proteomics, Chemoinformatic, Genomics, and Others), Sector (Medical Bioinformatics, Animal Bioinformatics, Agriculture Bioinformatics, Academics, and Others) and by Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Global trends and forecast from 2022 to 2029

Discomfort Management Devices Industry Development Tactics, Improvement Outlook, Competitive Landscape and Dynamic Innovations by 2029. The discomfort management sector is becoming driven by an enhance in the quantity of surgical operations undertaken.

Pain Management Devices Market by Type (Neurostimulation, RF Ablation, Infusion Pumps), Application (Neuropathy, Cancer, Facial, MSK, Migraine), Mode of Purchase (OTC, Prescription-based) and Region (Asia-pacific, North America, Europe, South America, Middle East & Africa) – Global Forecast from 2022 to 2029

Get in touch with: Irfan Tamboli (Head of Sales) – Exactitudeconsultancy Telephone: + 1704 266 3234

By Editor

One thought on “Bioprocess Technologies Industry is projected to Surpass USD 61805.63 million by 2029 at a CAGR of 15.two% from 2023 to 2029 industry expanding increasingly due to infectious and chronic illnesses”

Leave a Reply